Belgian consensus guidelines for follow-up of women with cervical cytological abnormalities

Acta Clinica Belgica

Volumn 64, Issue 2, 2009, Pages 136-143

  Cuvelier, C A ^a,j   Bogers, J P M ^b   Bourgain, C ^c   Delvenne, Ph ^d   Drijkoningen, M ^e   Garbar, C ^c   Kevers, M ^f   Remmelinck, M ^g   Thienpont, L ^h   Verhest, A ⁱ   Weynand, B ^f   Willocx, F ^c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e VIRGA JESSE HOSPITAL   (Belgium)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g ERASME HOSPITAL   (Belgium)

^h OLV HOSPITAL   (Belgium)

ⁱ UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^j GHENT UNIVERSITY   (Belgium)

more..

Author keywords

Belgium; Cervical cancer screening; Cytological abnormalities; Follow up guidelines

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; ARTICLE; ATYPICAL SQUAMOUS CELL; BELGIUM; CANCER SCREENING; COLPOSCOPY; CONSENSUS DEVELOPMENT; EARLY CANCER; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; PAPANICOLAOU TEST; POSTMENOPAUSE; PRACTICE GUIDELINE; PRECANCER; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS TYPING; WART VIRUS;

EID: 64949096138     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2009.023     Document Type: Article

References (31)

1. Papanicolaou GN. Cytological evaluation of smears prepared by the tampon method for the detection of carcinoma of the uterine cervix. Cancer 1954 7:1185-90.
2. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA 1989;262:931-4.
3. Broder S. From the National Institutes of Health. Rapid communication-The Bethesda System for reporting cervical/vaginal cytologic diagnoses-report of the 1991 Bethesda Workshop. JAMA 1992; 267:1892.
4. Solomon D, Davey D, Kurman R, et al.The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 2002; 287:2114-9.
5. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
6. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations. JAMA 2001;285:1500-5.
7. Sherman ME, Solomon D, Schiffman M. Qualification of ASCUS: A Comparison of Equivocal LSIL and Equivocal HSIL Cervical Cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol 2001; 116:386-94.
8. Jones BA, Novis DA. Follow-up of abnormal gynaecologic cytology: a College of American Pathologists Q-probes study of 16.132 cases from 306 laboratories. Arch Pathol Lab Med 2000; 124:665-71.
9. Flynn K, Rimm DL. Diagnosis of 'ASCUS' in women over age 50 is less likely to be associated with dysplasia. Diagn Cytopathol 2001; 24:132-6.
10. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995; 76:1888-1901.
11. Solomon D, Schiffman M.Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undertermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-9.
12. Bergeron C, Jeannel D, Podeva J, Cassonnet P, Orth G. Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 2000; 95:821-7.
13. American College of Obstetricians and Gynecologists. Cervical cytology: evaluation and management of abnormalities. Washington, DC: American College of Obstetricians and Gynecologists; 1993: 1-7. ACOG Technical Bulletin 183.
14. Mitchell MF, Schottenfeld D,Tortolero-Luna G, Cantor SB, Richards-Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;91:626-31.
15. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized atypical squamous cells of undertermined significance/low-grade squamous intraepithelial lesion triage study (ALTS). J Natl Cancer Inst 2002; 94:102-7.
16. Wright TC, Lorincz A, Ferris DG, et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears.Am J Obstet Gynecol 1998; 178:962-6.
17. ALTS-group. Results of a randomised trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.Am J Obstet Gynecol 2003; 188:1383-92.
18. Keating JT, Wang HH. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women. Cancer 2001; 93:100-5.
19. Jones BA, Davey DD. Quality management in gynaeco-logic cytology using interlaboratory comparison. Arch Pathol Lab Med 2000; 124:672-81.
20. Takezawa K, Bennett BB, Wilkinson EJ, Drew PA, Hardt NS. Squamous intraepithelial lesions of the cervix in a high-risk population.J Lower Gen Tract Dis 1998; 2:136-40.
21. Lonky NM, Sadeghi M, Tsadik GW, Petitti D. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynecol 1999; 181: 560-6.
22. 22.zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.J Natl Cancer Inst 2000; 92:690-8.
23. Robertson JH, Woudent BE, Elliott H. Cytological changes preceding cervical cancer.J Clin Pathol 1994; 47:278-9.
24. ALTS-Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000; 92:397-402.
25. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda System. Gynecol Oncol 2001; 82: 516-22.
26. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91:973-6.
27. 27.Grenko RT,Abendroth CS, Frauenhoffer EE, Ruggiero FM, Zaino RJ. Variance in the interpretation of cervical biopsy specimens obtained for atypical squamous cells of undetermined significance. Am J Clin Pathol 2000; 114: 735-40.
28. Milne DS.Wadehra V, Mennim D, Wagstaff TI.A prospective follow upstudy of women with colposcopically unconfirmed positive cervical smears. Br J Ostet Gynaecol 1999; 106:38-41.
29. Soofer SB, Sidawy MK. Atypical glandular cells of undetermined significance. Cancer 2000; 90:207-14.
30. Lee KR, Manna EA, St. John T. Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Diagn Cyto-pathol 1995; 13:202-8.
31. 31.Montz FJ. Significance of 'normal' endometrial cells in cervical cytology form asymptomatic postmenopausal women receiving hormone replacement therapy. Gynecol Oncol 2001;81:33-9.